CureCircleCureCircle
ConditionsValue your dataEvidenceGuidesFor research labsSign inShare your story

Evidence / What health data sells for

What health data sells for: every price found

Every published price for health data: licences, listings, offers, company sales and what it costs to obtain, per record, per test, per genome and per day, each with its source and its own words.

75 figures, last read 7 Nov 2026. Each row opens the figure with its source and its own words.

Data licences (16)

Genentech access to 23andMe genetic and phenotypic database for Parkinson's target discovery$10 million upfrontFierce Biotech, 23andMe strikes $60M Genentech deal to continue pivot to database-driven R&D (12 January 2015)GSK one-year nonexclusive licence to 23andMe de-identified genetic data, plus analysis services$20 million upfront23andMe press release, 23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK (30 October 2023) · checkedNHS EHR/EMR data, estimated market value per patient record<£100EY, How we can place a value on health care data (19 July 2019) · checkedNHS patient record linked with genomic and phenotypic data, estimated market value per record£1000–5000EY, How we can place a value on health care data (19 July 2019) · checkedGSK expanded access to the Tempus patient data platform for drug discovery and trial design$70 millionBioSpace, GSK Expands AI Footprint with $70M Tempus Deal (18 October 2022) · checkedRecursion licence of Tempus de-identified clinical and molecular records for AI model training, annual fee$22.0 million and $42.0 millionRecursion Pharmaceuticals Form 8-K, 9 November 2023 (Tempus master agreement) · checkedRecursion licence of Tempus de-identified records, total over the five-year term$160.0 millionRecursion Pharmaceuticals Form 8-K, 9 November 2023 (Tempus master agreement) · checkedStructured electronic health record data licence, one therapeutic area$1–3 millionDagenais et al., Clinical Pharmacology & Therapeutics 2022, Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design · checkedSpecialty unstructured EHR data needing extensive curation, one therapeutic area$3–5 millionDagenais et al., Clinical Pharmacology & Therapeutics 2022, Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design · checkedA Chinese public hospital's sale of a de-identified dataset of over 1,000 liver-disease clinical cases (clinical history and transplant status) to a company building an AI diagnostic model30,000 yuanThe Asia Business Daily (Asiae), "Hospitals Sell Patient Information: Medical Data Transactions Surge in China", 20 April 2026, reporting Caixin · checkedPathos licence fee spread over the size of the Tempus database (arithmetic over two stated numbers)$200 millionTempus AI, Inc. Form 10-K for fiscal year 2025 · checkedPathos AI licence of Tempus de-identified multi-modal oncology dataset to build a foundation model, three years$200 millionTempus AI, Inc. Form 10-K for fiscal year 2025 · checkedAnnual licence for large closed-network private-payer claims data, all therapeutic areas$400k–$800kDagenais et al., Clinical Pharmacology & Therapeutics 2022, Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design · checkedAnnual licence for large closed-network private-payer claims data, one therapeutic area$100k–300kDagenais et al., Clinical Pharmacology & Therapeutics 2022, Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design · checkedSmithKline Beecham's fee to Quest Diagnostics for Category One use (inside SmithKline and in its own disease programs) of Quest's encoded laboratory data, first licence periodUS $50,000Quest Diagnostics Form 8-K filed 1999-08-31, Exhibit 7: Category One Laboratory Data Access Agreement with SmithKline Beecham, dated August 16, 1999 · checkedEarly exclusive access to UK Biobank exome sequences, price paid by each pharmaceutical company in the Regeneron-led consortium, per exome$10 millionRegeneron press release (PR Newswire, 8 January 2018), as carried by BioSpace: Regeneron forms consortium of leading life sciences companies with UK Biobank · checked

Published price lists (28)

UK Biobank Tier 1 data access (questionnaires, physical measurements, health outcome phenotypes, linked health data), first three years£3,000UK Biobank, Fees (read from an Internet Archive copy, 2025; fees exclude VAT)CPRD linked hospital data (Hospital Episode Statistics, ONS death registration) added to a primary care study, per linked dataset£4,400 per datasetCPRD, pricing (prices applicable from April 2023, excluding VAT; read from an Internet Archive copy)CPRD Basic multi-study annual licence to UK primary care data, non-commercial£45,000CPRD, pricing (prices applicable from April 2023, excluding VAT; read from an Internet Archive copy)CPRD Full multi-study annual licence to UK primary care data (GOLD and Aurum), commercial£363,000CPRD, pricing (prices applicable from April 2023, excluding VAT; read from an Internet Archive copy)NHS England bespoke data linkage charge, per dataset per dissemination£2862NHS England, Data Access Request Service (DARS) charges, from 1 April 2026 (read from a mirror)HCUP National Inpatient Sample 2018, one year of US hospital discharge data (non-student price)$750AHRQ HCUP Nationwide Databases catalog, July 2021 · checkedLab results record sold through the MediPact researcher marketplace$0.24 per recordMediPact, guide for researchers (pricing table) · checkedUK Biobank Tier 2 data access (adds assays, proteomics, measured and imputed genotypes), first three years£6,000UK Biobank, Fees (read from an Internet Archive copy, 2025; fees exclude VAT)Medisafe's asking price for a one-year subscription to app users' own day-by-day logs of the doses they took, for one oncology drug class, on AWS Data Exchange$24,000.00AWS Marketplace (AWS Data Exchange), Medisafe Inc., Daily Medication Consumption Behavior - Oncology- Neutropenia (listing updated 5 December 2019) · checkedMedisafe's asking price for a one-year subscription to app users' own hour-by-hour logs of the doses they took, for one oncology drug class (neutropenia), on AWS Data Exchange$36,000.00AWS Marketplace (AWS Data Exchange), Medisafe Inc., Hourly Med Consumption Behavior - Oncology- Neutropenia (listing updated 5 December 2019) · checkedStanford AIMI's fixed fee for a company to use one of its de-identified clinical datasets (mostly medical images with reports) for one year$70,000 USD per datasetStanford Center for Artificial Intelligence in Medicine and Imaging (AIMI), Commercial Use of AIMI Datasets · checkedStanford AIMI's commercial licence fee spread over the studies in two of its imaging datasets (arithmetic over stated numbers)$70,000 USD per datasetStanford AIMI, Commercial Use of AIMI Datasets (fee); study counts from the AIMI CheXpert Plus and MRNet dataset pages · checkedOne AI data buyer's listed range for de-identified imaging studies and diagnostic tests with reports, per dataset$80,000 to $620,000OpenTrain, company data licensing for imaging and diagnostics centers · checkedUK Biobank Tier 3 data access (adds imaging, whole genome and whole exome sequence data), first three years£9,000UK Biobank, Fees (read from an Internet Archive copy, 2025; fees exclude VAT)One completed HCAHPS hospital patient-experience survey by mail, vendor price$10-$15 per completeCMS, Costs and Benefits of HCAHPS Final Report (October 5, 2005) · checkedOne completed HCAHPS hospital patient-experience survey by telephone, vendor price$16.67 - $20 per completeCMS, Costs and Benefits of HCAHPS Final Report (October 5, 2005) · checkedIn-depth interviews bought from a full-service US market research agency, all-in project price$5,000 to $15,000 per 10-15 interviewsDrive Research, How Much Does Market Research Cost · checkedOne completed online panel survey from a high-incidence consumer group, panel provider price$2-3proSapient, Paying the right price for your survey · checkedOne completed online panel survey from a low-incidence (0.5%) consumer group, panel provider price$8-$10proSapient, Paying the right price for your survey · checkedOne completed online panel survey, general audiencebetween $2 and $15 per completeQuestionPro, How Much Does a Survey Cost? 2026 Price Breakdown · checkedOne completed general-population health survey$10–$30 per respondentSimSurveys, Synthetic Data for Rare Disease Research · checkedOne completed survey from a recruited rare disease patient, before analysis and reporting$500–$2,000+ per completeSimSurveys, Synthetic Data for Rare Disease Research · checkedOne AI-moderated research interview from a 4M+ participant panel (floor of the buyer price ladder)$30 per quality interviewUser Intuition, Healthcare Qualitative Research Cost Guide (2026) · checkedParticipant incentive component inside the price of a patient interview, healthcare qualitative research$25-$75 for patient interviewsUser Intuition, Healthcare Qualitative Research Cost Guide (2026) · checkedOne 30 to 45 minute patient interview run by an experienced health research moderator, agency price$200-$300User Intuition, Healthcare Qualitative Research Cost Guide (2026) · checkedRecruiting one patient participant into a healthcare qualitative study, general range$100-$300 per ParticipantUser Intuition, Healthcare Qualitative Research Cost Guide (2026) · checkedRecruiting one rare disease patient participant into a healthcare qualitative study$500 per participantUser Intuition, Healthcare Qualitative Research Cost Guide (2026) · checkedOne traditional in-depth interview bought from a research agency$500-$1,500 per conversationUser Intuition, How Much Does Market Research Cost? (2026 Breakdown) · checked

Offers to people for their data (3)

LunaDNA's offer to people for each year of their historical health records (typed PDF reports from care providers and diagnostic labs), paid in shares$0.14LunaDNA, LLC, Regulation A offering circular filed with the SEC under Rule 253(g)(2), December 2021 (Member Data and shares table) · checkedLunaDNA's offer to people for each unique individual record of digital clinical data (a test result is one record type), paid in shares$0.07LunaDNA, LLC, Regulation A offering circular filed with the SEC under Rule 253(g)(2), December 2021 (Member Data and shares table) · checkedLunaDNA's offer to people for completing a health survey (family health history, own health, medications, environment, lifestyle), per 5 minutes of average completion time, paid in shares$0.07LunaDNA, LLC, Regulation A offering circular filed with the SEC under Rule 253(g)(2), December 2021 (Member Data and shares table, and Value of Consideration) · checked

Companies sold with their data, divided per record (9)

TTAM Research Institute's court-approved purchase of bankrupt 23andMe (genetic database, testing and research businesses)$305 millionGovInfoSecurity (ISMG), Court Approves 23andMe Sale to TTAM Research Institute (2 July 2025) · checkedTTAM's price for 23andMe spread over its customers (whole-company sale, arithmetic over two stated numbers)$305 million ... 15 million customersGovInfoSecurity (ISMG), Court Approves 23andMe Sale to TTAM Research Institute (2 July 2025) · checkedThermo Fisher's price for CorEvitas, a real-world-evidence registry company, spread over the patients its registries follow (whole-company acquisition, arithmetic over two stated numbers)$912.5 millionMedCity News, Thermo Fisher Adds Real-World Evidence to Remit Via $912M CorEvitas Acquisition, Frank Vinluan (6 July 2023) · checkedGE Medical Systems' winning bid for MedicaLogic's digital health record assets spread over the patients with records hosted on its systems (bankruptcy asset sale, arithmetic over two stated numbers)$35,250,000MedicaLogic/Medscape, Inc., Form 8-K Exhibit 99.1, GE Medical Systems winning bid (March 2002), sec.gov · checkedRoche's price for Flatiron Health spread over the patient records on its oncology platform (whole-company acquisition, arithmetic over two stated numbers)$1.9 billionAFP via The Local, Roche seals takeover of cancer data upstart Flatiron (6 April 2018) · checkedPRA Health Sciences' price for Symphony Health spread over the lives in its claims-based data asset (whole-company acquisition, arithmetic over two stated numbers)$530 millionPRA Health Sciences, Form 8-K Exhibit 99.1, PRA Health Sciences to acquire Symphony Health Solutions (7 August 2017), sec.gov · checkedEvidation's venture valuation spread over the members of its Achievement app, who share wearable data and answer health questionnaires (arithmetic over two stated numbers)$1 billionSanta Barbara Independent, Evidation Health Is Santa Barbara's Latest Billion-Dollar Baby, Tyler Hayden (14 April 2021) · checkedGoogle's price for Fitbit spread over Fitbit's active users (whole-company acquisition, arithmetic over two stated numbers)approximately $2.1 billionFitbit, Inc. Form 8-K Exhibit 99.1, Fitbit to be acquired by Google (1 November 2019), sec.gov · checkedThe 2017 iCarbonX-led investment in PatientsLikeMe spread over its members (money paid for part of a patient-community company, arithmetic over two stated numbers)at least $100 millionDiagnostics World News (Bio-IT World), PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance As Cornerstone, Allison Proffitt (9 January 2017) · checked

What it costs to obtain or make (14)

Abbott Lingo over-the-counter glucose biosensors: cost of the sensors that produce a day of CGM data (4-week plan)$89Abbott Lingo, plans page (hellolingo.com/products) · checkedDexcom Stelo over-the-counter glucose biosensors: cost of the sensors that produce a day of CGM data (one-time 1-month supply)$99.00Dexcom, Stelo Glucose Biosensor purchase page (stelo.com/en-us/buy-stelo-one-time) · checkedBlue Cross Blue Shield of Michigan's extra payment to a physician office for each LDL-C or HbA1c test billed with the CPT II code that reports the result$5Blue Cross Blue Shield of Michigan, The Record (provider newsletter), September 2013: "Laboratory fee increases for select physician office lab tests" · checkedCareSource North Carolina's bonus to a provider for each HbA1c result reported on a claim as a CPT II result code, for marketplace members with diabetes (any result band pays the same)$15.00CareSource North Carolina Co., provider notice NC-EXC-P-3167081 "Quality Enhancer for Submitting CPTII Codes for A1C", 7 November 2024 · checkedEmblemHealth's 2026 incentive to a primary care provider for each HbA1c result reported as a CPT II result code (any result band pays the same)$10EmblemHealth, "2026 Quality Incentive Program: CPT II Code Incentive" provider flyer · checkedTrinity Health Plan of Michigan's 2026 incentive to a network provider for each HbA1c result reported as a CPT II result code with a diabetes diagnosis code (each result band pays the same)$10Trinity Health Plan of Michigan (Medicare Advantage), "Incentive for Using CPT Category II Codes", plan year 2026 provider guide · checkedUNC Radiology Clinical Research Service Center charge to de-identify an imaging exam (disc or upload) for a research study$63University of North Carolina Department of Radiology, memo on Radiology Clinical Research Service Center core rates, 5 December 2024 · checkedResearch platform licence to collect one participant's Garmin wearable data (Fitrockr, research and clinical trials Basic plan), additional device licence, per participant-day$1-$8.5/monthFitrockr, Pricing page, Research and Clinical Trials plans (fitrockr.com/pricing) · checkedCost to a university of collecting Fitbit data (plus a monthly survey) from a six-month cohort of 55 participants, per participant-day$35 per participants per monthUniversity of Missouri Institute for Data Science and Informatics, eCaregiving 2.0 project summary (10 September 2018) · checkedWearable data API access (ROOK): Core plan for up to 750 active users, per user-day at full plan$399 USD per monthROOK, Pricing page (tryrook.io/pricing) · checkedWearable data API access (Terra): what an app pays to receive one consenting user's own wearable data stream, per user-day200 Unified API credits per monthTerra, Pricing page (tryterra.co/pricing) · checkedWearable data API access (Thryve, Germany): Start Up plan for 500 connected users, per user-day499 €Thryve, Pricing page (thryve.health/pricing) · checkedSequencing one exome (cost of producing genome-level data) in the Regeneron and GSK project on UK Biobank volunteersestimated cost of $150 million if all 500,000 participants are sequencedGEN, Regeneron, GSK, UK Biobank launch gene sequencing collaboration (23 March 2017) · checkedUK Biobank whole genome sequencing project: money paid by four pharmaceutical companies, per genome£100 millionGOV.UK (BEIS and UKRI), World's largest genetics project to tackle deadly diseases launches (11 September 2019) · checked

What studies pay participants (5)

Continuous glucose monitor data from a pregnant participant, payment per day with glucose values$1.50 for every day you wore the sensor with glucose valuesClinicalTrials.gov NCT06957028, informed consent form: CGM for early detection and management of hyperglycemia in pregnancy · checkedContinuous glucose monitor data from a young person with type 1 diabetes, payment per 14-day CGM data collection, per day$75 for each 3-month CGM data collectionClinicalTrials.gov NCT05413239, HAPPY T1D (Joslin Diabetes Center and Stanford), informed consent and assent form (30 January 2023) · checkedWearable and health-app activity data shared by a member with Evidation, reward per day at the maximum daily pointsup to 100 points per day; 10,000 points = $10Evidation, blog: how does Evidation work, collecting points · checkedWearable sensor data (heart rate, movement, breathing, sleep) contributed by a participant in a university study, reward per day of data$1University of Maryland, CATCH study (acute respiratory infection), consent form for the wearable portion (IRBNet package dated 21 September 2019)Fitbit smartwatch wear data from a participant in a physical activity study, payment for wearing it day and night through the study, per day$35ClinicalTrials.gov NCT06125964, University of Southern California eMOTION study, informed consent form (version 23 January 2024) · checked
CureCircleCureCircle

Share your health. Help find cures. Get paid. Health data for research, owned by the people who share it.

Product

  • Conditions
  • Value your data
  • Evidence
  • Guides
  • For research labs
  • Sign in

Legal

  • Privacy Policy
  • Terms of Service
  • Support
© 2026 CureCircle. All rights reserved.

Operated by O-mega Enterprise, Inc